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INTRODUCTION
Cardiovascular disease is the leading cause of mortality
among patients with end-stage renal disease. A carotid inti-
ma-media thickness of >0.9 mm and the presence of discrete
plaques are each considered markers of generalized atheroscle-
rosis, and are associated with cardiovascular risk factors (1, 2).
Vascular calcifications are common in patients with end-
stage renal disease (3). Such calcifications are believed to arise
from calcifications of the intimal layer of the vessel caused
by atherosclerotic changes, or calcifications of the medial wall
that correspond to Monckeberg’s arteriosclerosis (4). There
is strong evidence that calcifications contribute to cardiovas-
cular mortality not only in renal patients but also in patients
with non-insulin-dependent diabetes mellitus (DM), as well
as in the general population (5, 6).
One study reported that in end-stage renal disease, increased
intima-media thickness and presence of calcified plaque occurs
not only in central elastic arteries such as the aorta and carotid
but also in peripheral muscular-type arteries including the
femoral (7). Furthermore, carotid artery intima-media thick-
ness is linked to left ventricular hypertrophy in dialysis patients
(7). These findings suggest that some cardiac and vascular
changes may occur in parallel in dialysis patients.
There are two reports (8, 9) on the prevalence and significance
of a thickened intima-media layer and the presence of arterial
plaques in patients undergoing continuous ambulatory peri-
toneal dialysis (CAPD) in Korea. The present study examined
intima-media thickness and carotid and brachial artery plaque
prevalence in CAPD patients and healthy normotensive con-
trols. The study also sought to determine whether cardiac
and vascular changes occurred in parallel in dialysis patients.
We therefore investigated the prevalence of vascular calcifica-
tions and survival rates during 2-yr follow-up in 25 CAPD
patients in a single dialysis center.
MATERIALS AND METHODS
Patients
The study involved 50 subjects in total. Group 1 consist-
ed of 25 CAPD patients (14 men, 11 women; mean age 59
±11 yr) without clinical vascular disorders in a mean time
undergoing CAPD of 35 months (4-120 months). Group 2
consisted of 25 age- and sex-matched controls. Exclusion
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Continuous Ambulatory Peritoneal Dialysis Patients Show High 
Prevalence of Carotid Artery Calcification which is Associated 
with a Higher Left Ventricular Mass Index 
This study examined intima-media thickness and arterial plaque occurrence in the
carotid and brachial arteries in continuous ambulatory peritoneal dialysis (CAPD)
patients. The study compared 25 CAPD patients with 25 normotensive age- and
sex-matched controls. Intima-media thickness and presence of plaque in carotid
and brachial artery were measured three times using high-resolution B-mode echocar-
diography. Left ventricular mass was calculated using the Penn Convection equa-
tion. Blood samples were obtained to assess levels of phosphorus, total calcium,
serum albumin, C-reactive protein, and lipid profiles. Compared to the control group,
CAPD patients had greater mean carotid and brachial intima-media thickness, and
a higher proportion of subjects with calcified plaques. The left ventricular mass index
was higher in CAPD patients with carotid artery calcified plaques compared to CAPD
patients without carotid artery calcified plaques. CAPD patients with such plaque
were significantly associated with diabetes mellitus, higher C-reactive protein levels
and a lower 2-yr survival rate. The present study showed an high prevalence of
carotid calcification in CAPD patients and those with such calcification had a greater
incidence of diabetes mellitus, higher C-reactive protein levels and left ventricular
mass index, and a lower survival rate.
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criteria were patients with histories or signs of cardiac failure,
unstable angina pectoris, peripheral vascular disease, systolic
blood pressure >180 mmHg or diastolic blood pressure >105
mmHg, serum albumin <2.5 g/dL, intact-PTH level >200
pg/mL, serum total calcium level >11 mg/dL or serum phos-
phate level >7 mg/dL. Primary kidney disease patients com-
prised 14 with diabetes mellitus (DM) and 11 non-DM pati-
ents (Table 1).
Methods
Three distal wall measurements were taken to determine
the intima-media thickness of the common carotid artery
and brachial artery. These measurements were taken within
1 cm of the bifurcation using a high resolution B-mode duplex
ultrasound imager (7.5 MHz transducer, Hewlett-Packard,
Sonos2000
�, Bothell, Washington, U.S.A.) by the same trained
cardiologist on each occasion, and the mean of these measure-
ments was used in analysis. Intima-media thickness was defined
as the distance from the leading edge of the lumen-intima
interface of the far wall to the leading edge of the media-adven-
titia interface of the far wall, as validated by Pignoli et al. (10).
The intima-media cross-sectional areas (IMCSA) of the com-
mon carotid and brachial arteries were calculated as follows: 
-IMCSA=[ (D/2+IMT)2- (D/2)2]
(D=artery diameter at end-diastole, IMT=intima-media
thickness) (11)
Atherosclerotic plaques were classified as fibrous, mixed
or calcified based on comparisons made between B-mode
ultrasound observations of plaques (12, 13). Bright white
echoes denoted plaques of greater density, and represent min-
eralization and calcification. Patients were allowed to take
regular medication. The same nurses consecutively (5 times)
measured sitting blood pressure conventionally with a sphyg-
momanometer on the left side. The systolic blood pressure
and diastolic blood pressure data shown in the study repre-
sent the means of these 5 measurements. Mean arterial pres-
sure was calculated using the following formula, ‘systolic
blood pressure+2×diastolic blood pressure)/3’, while pulse
pressure was calculated in the following manner, ‘systolic
blood pressure-diastolic blood pressure’.
Baseline echocardiography was performed using a Hewlett-
Packard Sonos 100 device equipped with a 2.25-MHz probe,
allowing M-mode, 2-dimensional and pulsed Doppler mea-
surements. Measurements were made according to the rec-
ommendations of the American Society of Echocardiography.
Left ventricular mass was calculated according to the Penn
convention equation (14). Left ventricular hypertrophy was
defined as left ventricular mass index >125 g/m2 (7).
In the CAPD patient group, blood samples were analyzed
for phosphorus and total calcium concentration using an
Hitachi 747 automatic analyzer, with normal ranges con-
sidered as being 1.9-4.4 mg/dL and 8.2-10.4 mg/dL, respec-
tively. Intact-PTH was measured using a commercial immuno-
radiometric assay (Diagnostic products corporation, Los Ange-
les, CA, U.S.A.), and the normal range in our laboratory is
considered to be 12-72 pg/mL. Serum albumin was mea-
sured using an Hitachi 736-740 autoanalyzer (Hitachi Ltd,
Tokyo, Japan), and C-reactive protein was measured using a
COBAS INTEGRA (Roche Diagnostic Systems, Somerville,
NJ, U.S.A.). Serum total cholesterol, LDL-cholesterol, HDL-
cholesterol and triglyceride levels were measured by enzymatic
methods using an Hitachi 736-740 autoanalyzer. Just before
the examination echocardiography, all subjects had fasting
blood samples for above examinations. For patients, additional
analysis of the mean of the previous six samples over the pre-
ceding 6-month period was also included.
To evaluate the total Kt/V urea index (Kt/V) in CAPD
patients, the sum of 24 hr residual and dialytic urea clearances
was divided by the urea distribution volume which was cal-
culated using Watson’s nomogram. Residual renal function
(RRF) was estimated using the average of the residual urea
and creatinine clearances.
Parameters with Gaussian distribution are expressed as
mean±SD; between-group differences were assessed for sig-
nificance using unpaired t-tests and Mann-Whitney U tests
as appropriate (SPSS Windows version 9.0). Parameters with
skewed distribution are expressed as median and range; Wil-
coxon and Kruskal-Wallis testing was used for comparing
data from 2 groups. Dichotomized variables were compared
using Pearson’s chi-square test or Fisher’s exact test. Spear-
man’s correlation coefficients were used to express association
between parameters. Differences were considered significant
if the p value was less than 0.05.
Data represent mean±S.D., or median (range).
DM, diabetes mellitus; CAPD, continuous ambulatory peritoneal dialysis;
Ca, calcium; P, phosphorus; LDL, low density lipoprotein; HDL, high
density lipoprotein; PTH, parathyroid hormone.
Variables CAPD group
Age (yr) 59±11
Men/Women (n) 14/11
DM/non-DM (n) 14/11
CAPD duration (mo) 35 (4-120)
Total Kt/Vurea 2.03±0.51
Residual renal function (mL/min) 2.3 (1-6.5)
Serum albumin level (g/dL) 3.4±0.5
C-reactive protein (mg/L) 12.2 (3.0-29.7)
Serum calcium level (mg/dL) 8.4±0.6
Serum phosphorus level (mg/dL) 4.8±1.9
Ca x P product (mg/dL) 39.70±14.39
Total cholesterol level (mg/dL) 191±39
LDL-cholesterol level (mg/dL) 111±31
HDL-cholesterol level (mg/dL) 44±9
PTH level (pg/mL) 90.71±27.03
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RESULTS
Intima-media thickness, left ventricular mass index and
calcified plaque occurrence in the common carotid and
brachial arteries of CAPD patients and normal controls
We found that both the carotid and brachial artery intima-
media layers were thicker in the CAPD group compared to
control group (carotid: 0.75±0.30 vs. 0.60±0.16 mm, p=
0.003; brachial: 0.46±0.07 vs. 0.38±0.08 mm, p=0.002).
Similarly, the mean carotid and brachial intima-media cross-
sectional areas were greater in the CAPD group compared
to control group (carotid: 64.4±31.5 vs. 44.5±11.6, p=
0.03; brachial: 21.1±0.1 vs. 15.9±0.1, p=0.02). Com-
pared to controls, the mean left ventricular mass index was
higher in the CAPD group (168.0±60.8 vs. 99.0±20.7,
p=0.04). The proportion of subjects with calcified plaques
was also higher in the CAPD patient group compared to
controls (14/25 (56%) vs. 2/25 (8%), p=0.01) (Table 2). We
found that while 14 patients had discrete carotid artery cal-
cified plaques, only three of these (2 males, 1 female) had a
carotid intima-media thickness >0.9 mm.
Correlations between left ventricular mass index and inti-
ma-media thickness, and intima-media cross-sectional
area in common carotid and brachial arteries
In CAPD patients, common carotid artery intima-media
thickness correlated well with brachial artery intima-media
thickness (r=0.5949, p<0.01) (Fig. 1). In CAPD patients, neither
common carotid artery intima-media thickness nor common
carotid artery intima-media cross-sectional area correlated
with left ventricular mass index (r=0.167, p=0.54 and r=
0.261, p=0.45, respectively), and similarly, neither brachial
artery intima-media thickness nor brachial intima-media cross-
sectional area correlated with left ventricular mass index (r=
0.115, p=0.34 and r=0.056, p=0.78, respectively). In contrast,
the left ventricular mass index was greater in CAPD patients
with calcified plaques in the carotid artery (Table 3) and signifi-
cantly correlated with carotid calcification (r=0.561, p=0.04).
Comparisons between CAPD patients with and without
calcified plaques
Compared to CAPD patients without carotid artery calci-
Data represent mean±S.D. *p<0.05 versus control group.
IMT, intima-media thickness; IMTA, intima-media thickness area; LVM
index, left ventricular mass index; CCA, common carotid artery; BA, bra-
chial artery; SBP, systolic blood pressure; DBP, diastolic blood pressure;
MAP, mean arterial pressure; PP, pulse pressure.
CAPD group Control group
Age (yr) 59±12 59±11
Men/Women (n) 14/11 14/11
Calcified plaque (%) 2/25 (8%) 14/25 (56%)*
CCA-IMT (mm) 0.60±0.16 0.75±0.30*
CCA-IMTA (mm
2) 44.5±11.6 64.4±31.5*
BA-IMT (mm) 0.38±0.08 0.46±0.07*
BA-IMTA (mm
2) 15.9±0.1 21.1±0.1*
LVM index (g/m
2) 99.0±20.7 168.0±60.8*
SBP (mmHg) 126±16 152±18*
DBP (mmHg) 78±98 8 ±10*
MAP (mmHg) 94±11 109±12*
PP (mmHg) 48±96 3 ±13*
Table 2. IMT, LVM index and calcified plaque occurrence in CCA
and BA of CAPD patients and control subjects 
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Fig. 1. Correlation between common carotid artery intima-media
thickness and brachial artery intima-media thickness.
CCA-IMT, common carotid artery intima-media thickness; BA-IMT,
brachial artery intima-media thickness. 
Data represent mean±S.D., or median (range).
*p<0.05 versus calcified plaque group.
With calcified
plaque
Without calcified
plaque
Age (yr) 58±66 0 ±16
Men/Women (n) 9/5 5/6
DM/non-DM (n) 11/14 (79%) 4/11 (36%)*
CCA-IMT (mm) 0.83±0.36 0.65±0.17
CCA-IMTA (mm
2) 78.81±38.99 56.21±16.31
BA-IMT (mm) 0.49±0.07 0.43±0.06
BA-IMTA (mm
2 23.20±0.73 21.15±0.15
LVM index (g/m
2) 199±78 144±26*
Serum albumin level (g/dL) 3.34±0.47 3.45±0.55
C-reactive protein (mg/L) 16.5 (6.9-29.7) 9.3 (3.0-16.1)*
Serum calcium level (mg/dL) 8.47±0.47 8.27±0.79
Serum phosphorus level (mg/dL) 4.34±1.41 5.30±1.29
Ca x P product (mg/dL) 36.67±11.38 43.54±17.29
Total cholesterol level (mg/dL) 183±44 201±30
LDL-cholesterol level (mg/dL) 100±27 123±37
HDL-cholesterol level (mg/dL) 41±94 8 ±6
Triglyceride (mg/mL) 200±167 155±58
Total cholesterol/HDL-cholesterol  4.57±1.25 4.43±0.99
LDL- cholesterol/HDL-cholesterol  2.50±0.71 2.71±0.79
2-yr survival (%) 7/14 (50) 8/11 (73)*
Table 3. Comparisons between CAPD patients with and without
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fied plaques, CAPD patients with such plaques had a greater
incidence of diabetes mellitus (79 vs. 36%, p=0.04), greater
C-reactive protein levels (16.5 (6.9-29.7) vs. 9.3 (3.0-16.1),
p=0.02), higher left ventricular mass index (199±78 vs. 144
±26, p=0.04) and a lower 2-yr survival rate (50 vs. 73%,
p=0.04) (Table 3). All deaths in carotid calcified plaque pati-
ents comprised 4 cerebrovascular accidents, 2 ischemic coro-
nary events and 1 death from peripheral vascular disease with
sepsis.
DISCUSSION
The present study revealed an extremely high prevalence
of advanced calcifying plaque in the carotid arteries of CAPD
patients. Carotid calcifications were observed in 56% of CAPD
patients compared to 8% of controls. These data are consis-
tent with those of Savage et al. showing calcified plaques are
common in the carotid arteries of CAPD patients without
clinical vascular disease (7). Expectedly, we found that all of
the calcified plaques were found in the carotid artery. In addi-
tion, we found that carotid and brachial artery intima-media
thicknesses were greater than those of matched control sub-
jects. Unexpectedly, intima-media thickness was not always
associated with the presence of plaque in the same vessel.
Left ventricular hypertrophy has been shown to indepen-
dently predict cardiovascular mortality in end-stage renal
disease patients (15). Roman et al. reported a positive inde-
pendent association between carotid intima-media thickness
and left ventricular end-diastolic diameter (16). London et al.
found both ventricular diameters and left ventricular mass
correlated with carotid intima-media thickness (17). In the
present study, common carotid artery intima-media thickness
and intima-media cross-sectional area correlated well with
those of the brachial artery. However, intima-media thick-
ness and intima-media cross-sectional area of the common
carotid or brachial artery did not correlate with left ventric-
ular mass index. Indeed, the left ventricular mass index was
higher in CAPD patients with calcified plaques in the carotid
artery. Given these data refer to discrete calcified plaques rather
than continuous plaques, it appears that calcification per se,
especially in a central artery such as the common carotid,
directly influences left ventricular mass index in CAPD patients.
This hypothesis appears to be supported by the reports of
both Guerin et al. and London et al. showing that the pres-
ence of vascular calcification was associated with increased
stiffness in larger arteries, and that this stiffness may have
important clinical consequences partly due to its association
with increased systolic blood pressure and concentric left ven-
tricular hypertrophy (11, 18). Moreover, increased stiffening
of the large arteries was found to be an important predictor
of mortality in renal patients (19). The present study found
that the 2-yr survival rate in patients with carotid calcified
plaques was lower than in patients without carotid calcified
plaques. We found that all deaths in carotid calcified plaque
patients were due to cardiovascular disease. According to Oh
et al., end-stage renal disease patients have a high prevalence
of vascular calcification associated with microinflammation,
high PTH, calcium-phosphate product and homocysteine,
but not traditional atherogenic risk factors (20). Hyperparathy-
roidism, calcium-phosphate overload and hyperhomocysteine-
mia are modifiable and treatable disorders. To elucidate the
association between the above factors and vascular calcifica-
tion, we conducted a study which excluded patients with
uncontrolled hypertension, severe malnutrition, established
infection, high serum intact-PTH and total calcium and phos-
phate levels. We found that CAPD patients with carotid artery
calcified plaques had a greater incidence of diabetes mellitus
and had higher C-reactive protein levels compared to CAPD
patients without carotid artery calcified plaques. There were
no positive correlations between carotid calcified plaques and
other parameters such as age, sex, CAPD duration, intima-
media thickness, hyperlipidemia, blood pressure and serum
albumin level.
In addition to atherosclerotic changes, the vessels in DM
patients are characterized by increased amounts of connective
tissue such as fibronectin, collagen and glycoprotein, and
increased amounts of calcium in the medial layer of the arte-
rial wall. The pathogenesis and high prevalence of medial
artery calcification in DM patients, also known as Moncke-
berg’s arteriosclerosis, remain the subjects of debate. Given
the present study did not involve histological examination
of the carotid or brachial arteries, we cannot state whether
patients had reached the final stage of atherosclerosis, or
whether a Monckeberg’s arteriosclerosis, as described previ-
ously in diabetic and uremic patients, was responsible for
the prevalence of calcified plaques.
The acute-phase protein C-reactive protein is chronically
elevated in one third to two thirds of dialysis patients (21).
C-reactive protein is considered a surrogate marker of a microin-
flammatory state, and is a powerful predictor of general and
cardiovascular mortality both in the general and in the end-
stage renal disease population (21, 22). We demonstrated
here that C-reactive protein levels were higher in carotid cal-
cification patients. Multiple inflammatory mechanisms are
implicated in the initiation and propagation of atherosclerotic
lesions (23). C-reactive protein may be directly involved as
it binds to degraded LDL particles, is deposited at the intima-
media interface, co-localizes with complement, and attracts
monocytes to atherosclerotic lesions (21). Moreover, calcifica-
tion of vascular cells and atheromatous lesions is directly stim-
ulated by TNF- , a proinflammatory cytokine that also pro-
motes C-reactive protein release (24). We believe that further
study aimed at elucidating the mechanisms underlying the
higher prevalence of vascular calcification in patients with
DM and high C-reactive protein levels is warranted.
In conclusion, the present study revealed an extremely high
prevalence of carotid calcification in CAPD patients without
. .
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clinical vascular disorders. Patients with carotid calcification
had a greater incidence of DM, higher C-reactive protein
levels and left ventricular mass index, and a lower survival
rate. Therefore, it appears that optimal peritoneal dialysis
treatment should aim to reduce factors that contribute to
inflammation, such as bioincompatibility of solutions, fluid
overload, loss of residual renal function, increased body fat
mass and peritonitis.
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